國家級人體生物資料庫整合平台共同資料模式實作指引(NBCT Common Data Model IG)
0.1.0 - trial-use
This page is part of the 國家級人體生物資料庫整合平台共同資料模式實作指引(NBCT Common Data Model IG) (v0.1.0: Releases) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions
| Active as of 2024-08-01 |
{
"resourceType" : "CodeSystem",
"id" : "ssf-1-leukemia-codesystem",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: CodeSystem ssf-1-leukemia-codesystem</b></p><a name=\"ssf-1-leukemia-codesystem\"> </a><a name=\"hcssf-1-leukemia-codesystem\"> </a><a name=\"ssf-1-leukemia-codesystem-en-US\"> </a><p>This case-sensitive code system <code>https://www.ghd.tw/cdm-fhir/fhir/CodeSystem/ssf-1-leukemia-codesystem</code> defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td style=\"white-space:nowrap\">000<a name=\"ssf-1-leukemia-codesystem-000\"> </a></td><td>正常</td></tr><tr><td style=\"white-space:nowrap\">001<a name=\"ssf-1-leukemia-codesystem-001\"> </a></td><td>AML with t(8;21)(q22;q22.1</td></tr><tr><td style=\"white-space:nowrap\">002<a name=\"ssf-1-leukemia-codesystem-002\"> </a></td><td>AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)</td></tr><tr><td style=\"white-space:nowrap\">003<a name=\"ssf-1-leukemia-codesystem-003\"> </a></td><td>Acute promyelocytic leukemia with t(15;17)</td></tr><tr><td style=\"white-space:nowrap\">004<a name=\"ssf-1-leukemia-codesystem-004\"> </a></td><td>AML with t(9;11)(p21.3;q23.3)</td></tr><tr><td style=\"white-space:nowrap\">005<a name=\"ssf-1-leukemia-codesystem-005\"> </a></td><td>AML with t(6;9)(p23;q34.1)</td></tr><tr><td style=\"white-space:nowrap\">006<a name=\"ssf-1-leukemia-codesystem-006\"> </a></td><td>AML with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2)</td></tr><tr><td style=\"white-space:nowrap\">007<a name=\"ssf-1-leukemia-codesystem-007\"> </a></td><td>AML (megakaryoblastic) with t(1;22)(p13.3;q13.1)</td></tr><tr><td style=\"white-space:nowrap\">013<a name=\"ssf-1-leukemia-codesystem-013\"> </a></td><td>AML with t(9;22)(q34;q11)</td></tr><tr><td style=\"white-space:nowrap\">021<a name=\"ssf-1-leukemia-codesystem-021\"> </a></td><td>B lymphoblastic leukemia / lymphoma with t(9;22)(q34.1;q11.2)</td></tr><tr><td style=\"white-space:nowrap\">022<a name=\"ssf-1-leukemia-codesystem-022\"> </a></td><td>B lymphoblastic leukemia / lymphoma with t(v;11q23.3)</td></tr><tr><td style=\"white-space:nowrap\">023<a name=\"ssf-1-leukemia-codesystem-023\"> </a></td><td>B lymphoblastic leukemia / lymphoma with t(12;21)(p13.2;q22.1)</td></tr><tr><td style=\"white-space:nowrap\">024<a name=\"ssf-1-leukemia-codesystem-024\"> </a></td><td>B lymphoblastic leukemia / lymphoma with hyperdiploidy</td></tr><tr><td style=\"white-space:nowrap\">025<a name=\"ssf-1-leukemia-codesystem-025\"> </a></td><td>B lymphoblastic leukemia / lymphoma with hypodiploidy (hypodiploid ALL)</td></tr><tr><td style=\"white-space:nowrap\">026<a name=\"ssf-1-leukemia-codesystem-026\"> </a></td><td>B lymphoblastic leukemia / lymphoma with t(5;14)(q31.1;q32.1)</td></tr><tr><td style=\"white-space:nowrap\">027<a name=\"ssf-1-leukemia-codesystem-027\"> </a></td><td>B lymphoblastic leukemia / lymphoma with t(1;19)(q23;p13.3)</td></tr><tr><td style=\"white-space:nowrap\">041<a name=\"ssf-1-leukemia-codesystem-041\"> </a></td><td>Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2)</td></tr><tr><td style=\"white-space:nowrap\">042<a name=\"ssf-1-leukemia-codesystem-042\"> </a></td><td>Mixed phenotype acute leukemia with t(v;11q23.3)</td></tr><tr><td style=\"white-space:nowrap\">051<a name=\"ssf-1-leukemia-codesystem-051\"> </a></td><td>Chronic myelogenous leukemia，t(9;22)</td></tr><tr><td style=\"white-space:nowrap\">061<a name=\"ssf-1-leukemia-codesystem-061\"> </a></td><td>Myelodysplastic syndrome associated with isolated del(5q-)</td></tr><tr><td style=\"white-space:nowrap\">090<a name=\"ssf-1-leukemia-codesystem-090\"> </a></td><td>(1) 一種異常，其他上述未列之染色體異常 (2) 二種異常，其中一種非上述之染色體異常 (3) 二種異常，二種皆非上述之染色體異常</td></tr><tr><td style=\"white-space:nowrap\">091<a name=\"ssf-1-leukemia-codesystem-091\"> </a></td><td>同時有兩種上述之染色體異常</td></tr><tr><td style=\"white-space:nowrap\">092<a name=\"ssf-1-leukemia-codesystem-092\"> </a></td><td>複雜之染色體異常，指三項(含)以上的染色體變化者</td></tr><tr><td style=\"white-space:nowrap\">8XX<a name=\"ssf-1-leukemia-codesystem-8XX\"> </a></td><td>Chromosome study after chemotherapy or immunotherapy or target therapy</td></tr><tr><td style=\"white-space:nowrap\">988<a name=\"ssf-1-leukemia-codesystem-988\"> </a></td><td>不適用。(1) ICD-O-3 M-9811-9837 (EXCEPT C42.0, 42.1, 42.4)</td></tr><tr><td style=\"white-space:nowrap\">998<a name=\"ssf-1-leukemia-codesystem-998\"> </a></td><td>有執行染色體檢查，但結果無法判斷</td></tr><tr><td style=\"white-space:nowrap\">999<a name=\"ssf-1-leukemia-codesystem-999\"> </a></td><td>病歷未記載或不詳或未執行染色體檢查</td></tr></table></div>"
},
"url" : "https://www.ghd.tw/cdm-fhir/fhir/CodeSystem/ssf-1-leukemia-codesystem",
"version" : "0.1.0",
"name" : "SSF1leukemiaCS",
"title" : "SSF1 白血病-白血病染色體檢查的評估代碼系統",
"status" : "active",
"experimental" : false,
"date" : "2024-08-01T15:33:47+08:00",
"publisher" : "國家級人體生物資料庫整合平台",
"contact" : [
{
"telecom" : [
{
"system" : "url",
"value" : "https://ghd.tw/"
}
]
}
],
"description" : "Assessment of chromosome study in leukemia Code System",
"caseSensitive" : true,
"content" : "complete",
"count" : 27,
"concept" : [
{
"code" : "000",
"display" : "正常"
},
{
"code" : "001",
"display" : "AML with t(8;21)(q22;q22.1"
},
{
"code" : "002",
"display" : "AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)"
},
{
"code" : "003",
"display" : "Acute promyelocytic leukemia with t(15;17)"
},
{
"code" : "004",
"display" : "AML with t(9;11)(p21.3;q23.3)"
},
{
"code" : "005",
"display" : "AML with t(6;9)(p23;q34.1)"
},
{
"code" : "006",
"display" : "AML with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2)"
},
{
"code" : "007",
"display" : "AML (megakaryoblastic) with t(1;22)(p13.3;q13.1)"
},
{
"code" : "013",
"display" : "AML with t(9;22)(q34;q11)"
},
{
"code" : "021",
"display" : "B lymphoblastic leukemia / lymphoma with t(9;22)(q34.1;q11.2)"
},
{
"code" : "022",
"display" : "B lymphoblastic leukemia / lymphoma with t(v;11q23.3)"
},
{
"code" : "023",
"display" : "B lymphoblastic leukemia / lymphoma with t(12;21)(p13.2;q22.1)"
},
{
"code" : "024",
"display" : "B lymphoblastic leukemia / lymphoma with hyperdiploidy"
},
{
"code" : "025",
"display" : "B lymphoblastic leukemia / lymphoma with hypodiploidy (hypodiploid ALL)"
},
{
"code" : "026",
"display" : "B lymphoblastic leukemia / lymphoma with t(5;14)(q31.1;q32.1)"
},
{
"code" : "027",
"display" : "B lymphoblastic leukemia / lymphoma with t(1;19)(q23;p13.3)"
},
{
"code" : "041",
"display" : "Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2)"
},
{
"code" : "042",
"display" : "Mixed phenotype acute leukemia with t(v;11q23.3)"
},
{
"code" : "051",
"display" : "Chronic myelogenous leukemia，t(9;22)"
},
{
"code" : "061",
"display" : "Myelodysplastic syndrome associated with isolated del(5q-)"
},
{
"code" : "090",
"display" : "(1) 一種異常，其他上述未列之染色體異常 (2) 二種異常，其中一種非上述之染色體異常 (3) 二種異常，二種皆非上述之染色體異常"
},
{
"code" : "091",
"display" : "同時有兩種上述之染色體異常"
},
{
"code" : "092",
"display" : "複雜之染色體異常，指三項(含)以上的染色體變化者"
},
{
"code" : "8XX",
"display" : "Chromosome study after chemotherapy or immunotherapy or target therapy"
},
{
"code" : "988",
"display" : "不適用。(1) ICD-O-3 M-9811-9837 (EXCEPT C42.0, 42.1, 42.4)"
},
{
"code" : "998",
"display" : "有執行染色體檢查，但結果無法判斷"
},
{
"code" : "999",
"display" : "病歷未記載或不詳或未執行染色體檢查"
}
]
}